Volitionrx (VNRX) EPS (Basic) Growth (1y) (2013 - 2025)
Volitionrx (VNRX) EPS (Basic) Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -18.87% |
| 2 | Stryker | 129.08 Bn | 126.21 Bn | 3.81 Bn | 13.56% |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 68.52 Bn | 67.07 Bn | 3.61 Bn | 97.93% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 92.23% |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.88 Bn | 1.98 Bn | -29.95% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.37 Bn | 21.25 Bn | 2.07 Bn | 114.97% |
| 10 | Volitionrx | 89,052.33 | -1.03 Mn | - | 101.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 101.63% |
| Sep 30, 2025 | 66.78% |
| Jun 30, 2025 | 142.85% |
| Mar 31, 2025 | -59,498.28% |
| Dec 31, 2024 | -6,395.75% |
| Sep 30, 2024 | 38.13% |
| Jun 30, 2024 | 40.33% |
| Mar 31, 2024 | 30.02% |
| Dec 31, 2023 | 6.68% |
| Sep 30, 2023 | 22.40% |
| Jun 30, 2023 | -9,358.21% |
| Mar 31, 2023 | -9,442.49% |
| Dec 31, 2022 | 14.26% |
| Sep 30, 2022 | -2.79% |
| Jun 30, 2022 | 70.35% |
| Mar 31, 2022 | 743.93% |
| Dec 31, 2021 | -29,151.94% |
| Sep 30, 2021 | -78,513.78% |
| Jun 30, 2021 | 574.51% |
| Mar 31, 2021 | 100.13% |